Thalys Medical Technology Group Inc. (603716.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.1B
Enterprise Value4.21B
P/E Ratio-13.05
PEG Ratio-0.51
Price/Sales Ratio3.19
Price/Book Ratio2.86
Enterprise/Revenue3.44
Enterprise/EBITDA-32.91

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.22
Operating Margin-0.16
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.21

Income Statement

Revenue1.08B
Revenue/Share4.54
Gross Profit240.33M
EBITDA-74.79M
Net Income-207.28M
Diluted EPS-1.04

Balance Sheet

Total Cash137.25M
Total Cash/Share0.64
Total Debt376.62M
Total Debt/Equity0.37
Current Ratio1.61
Book Value Per Share4.61

Price History

52-Week Change-44.84
52-Week High38.12
52-Week Low12.92
Moving Average 50 Days17.42
Moving Average 200 Days21.61

Statistics

Average Volume11.71M
Shares Outstanding225.79M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor5:2
Last Split DateApril 25, 2018
AD